These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11810937)

  • 1. [Treatment of diabetic patients with necrotic lesions of the foot].
    Astakhova IN
    Khirurgiia (Mosk); 2001; (12):34-7. PubMed ID: 11810937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical strategy in treatment of diabetic foot].
    Cen S; Huang F; Zhao J; Lu W; Wang C; Ran X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):803-6. PubMed ID: 18681279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Method for improving results of local operations for pyo-necrotic disease of the foot associated with diabetes mellitus].
    Grekova NM; Lebedeva IuV; Bordunovskiĭ VN
    Vestn Khir Im I I Grek; 2003; 162(5):78-81. PubMed ID: 14768112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anesthesia in surgical treatment of pyo-necrotic forms of diabetic foot].
    Ovechkin AM; Khmel'kova EIu; Gnezdilov AV; Gur'eva IV; Voronin AV; Kudriavtsev NG; Panteleev MI
    Khirurgiia (Mosk); 1999; (10):57-9. PubMed ID: 10540556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [NO-therapy in the treatment of purulent and necrotic lesions of lower extremities in diabetic patients].
    Shulutko AM; Antropova NV; Kriuger IuA
    Khirurgiia (Mosk); 2004; (12):43-6. PubMed ID: 15699957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Substantiation and varieties of complex surgical treatment tactics for pyo-necrotic forms of diabetic foot].
    Zemlianoĭ AB; Pal'tsyn AA; Svetukhin AM; Korotkina RN; Elagina LV; Pavlova MV; Terekhova RP; Kolokol'chikova EG; Bozh'eva EI; Makhmudova LS; Lebedeva AN; Ivanov LO
    Khirurgiia (Mosk); 1999; (10):44-8. PubMed ID: 10540553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term evaluation of chronic diabetic foot ulcers, non-healed after hyperbaric oxygen therapy].
    Albuquerque E Sousa J
    Rev Port Cir Cardiotorac Vasc; 2005; 12(4):227-37. PubMed ID: 16474863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers.
    Richard JL; Sotto A; Jourdan N; Combescure C; Vannereau D; Rodier M; Lavigne JP;
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):363-9. PubMed ID: 18632297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Syndrome of diabetic foot and atherosclerosis of the lower extremity arteries].
    Kokobelian AR; Zigmantovich IuM
    Vestn Khir Im I I Grek; 2006; 165(3):74-8. PubMed ID: 16881182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers.
    Duzgun AP; Satir HZ; Ozozan O; Saylam B; Kulah B; Coskun F
    J Foot Ankle Surg; 2008; 47(6):515-9. PubMed ID: 19239860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective review of free gracilis muscle flaps in the management of nonhealing diabetic foot ulceration.
    Osiogo FO; Lai CS; Wang WH; Chye YF; Lin SD
    J Foot Ankle Surg; 2006; 45(4):252-60. PubMed ID: 16818153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrasonic cavitation and ozonization in treatment of patients with pyo-necrotic complications of diabetic foot syndrome].
    Zubarev PN; Risman BV
    Vestn Khir Im I I Grek; 2011; 170(1):48-53. PubMed ID: 21506355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Central hemodynamics during epidural anesthesia in patients with pyonecrotic forms of diabetic foot].
    Orudzheva SA; Chistov AS; Zviagin AA; Sashurina LP
    Anesteziol Reanimatol; 2002; (3):39-41. PubMed ID: 12221875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers.
    Brem H; Tomic-Canic M; Tarnovskaya A; Ehrlich HP; Baskin-Bey E; Gill K; Carasa M; Weinberger S; Entero H; Vladeck B
    Surg Technol Int; 2003; 11():161-7. PubMed ID: 12931298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric analysis of skin microvasculature in the diabetic foot.
    Yusof MI; Al-Astani AD; Jaafar H; Rashid FA
    Singapore Med J; 2008 Feb; 49(2):100-4. PubMed ID: 18301834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifty percent area reduction after 4 weeks of treatment is a reliable indicator for healing--analysis of a single-center cohort of 704 diabetic patients.
    Coerper S; Beckert S; Küper MA; Jekov M; Königsrainer A
    J Diabetes Complications; 2009; 23(1):49-53. PubMed ID: 18394932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fresh fibroblast allografts in the treatment of diabetic foot ulcers.
    Han SK; Kim HS; Kim WK
    Dermatol Surg; 2009 Sep; 35(9):1342-8. PubMed ID: 19500128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of diabetic foot management with Circulat.
    Olalde JA; Magarici M; Amendola F; del Castillo O; Gonzalez S; Muhammad A
    Phytother Res; 2008 Oct; 22(10):1292-8. PubMed ID: 18570216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile and management outcome of diabetic foot ulcers in a tertiary care hospital.
    Mehmood K; Akhtar ST; Talib A; Talib A; Abbasi B; Siraj-ul-Salekeen ; Naqvi IH
    J Coll Physicians Surg Pak; 2008 Jul; 18(7):408-12. PubMed ID: 18760063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience in the use of vessel due F (sulodexide) in patients with suppurative-necrotic forms of diabetic foot without critical ischemia].
    Svetukhin AM; Zemlianoĭ AB; Orudzheva SA; Titova MI; Rudneva VG; Elagina LV; Pavlova MV; Terekhova RP; Bozh'eva EI; Makhmudova LS
    Ter Arkh; 2001; 73(4):31-3. PubMed ID: 11494443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.